The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

NCT03673215 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Recombinant human thrombopoietin
DRUG: Recombinant human thrombopoietin
DRUG: Placebo
DRUG: Recombinant human thrombopoietin
DRUG: Placebo
DRUG: recombinant human thrombopoietin
DRUG: placebo
DRUG: Recombinant human thrombopoietin
DRUG: placebo

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.